Cargando…

Real-world practice patterns for patients with advanced non-small cell lung cancer: multicenter retrospective cohort study in Japan

BACKGROUND: Recommended therapies for advanced/metastatic non-small cell lung cancer (NSCLC) have changed with the advent of targeted therapies. The objectives of this retrospective chart review study were to describe treatment patterns, biomarker testing practices, and health care resource use for...

Descripción completa

Detalles Bibliográficos
Autores principales:	Isobe, Hiroshi, Mori, Kiyoshi, Minato, Koichi, Katsura, Hideki, Taniguchi, Kazuko, Arunachalam, Ashwini, Kothari, Smita, Cao, Xiting, Kato, Terufumi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2017
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5661576/ https://www.ncbi.nlm.nih.gov/pubmed/29123433 http://dx.doi.org/10.2147/LCTT.S140491

Ejemplares similares

Real-World Treatments and Clinical Outcomes in Advanced NSCLC without Actionable Mutations after Introduction of Immunotherapy in Japan
por: Nokihara, Hiroshi, et al.
Publicado: (2022)

Health care resource use among patients with advanced non-small cell lung cancer: the PIvOTAL retrospective observational study
por: Lee, Dae Ho, et al.
Publicado: (2018)

Real-world first-line treatment and overall survival in non-small cell lung cancer without known EGFR mutations or ALK rearrangements in US community oncology setting
por: Abernethy, Amy P., et al.
Publicado: (2017)

First-Line Pembrolizumab Monotherapy for Advanced NSCLC With Programmed Death-Ligand 1 Expression Greater Than or Equal to 50%: Real-World Study Including Older Patients in Japan
por: Goto, Yasushi, et al.
Publicado: (2022)

Safety and effectiveness of secukinumab in psoriasis vulgaris and psoriatic arthritis: Real‐world evidence in Japan
por: Fujita, Hideki, et al.
Publicado: (2020)

Molecular testing and treatment patterns for patients with advanced non-small cell lung cancer: PIvOTAL observational study
por: Lee, Dae Ho, et al.
Publicado: (2018)

Real‐world outcomes of pembrolizumab monotherapy in non‐small cell lung cancer in Japan: A post‐marketing surveillance
por: Yamamoto, Nobuyuki, et al.
Publicado: (2022)

Biopsy Procedures and Molecular Testing Utilization and Related Costs in Patients with Metastatic Lung Cancer
por: Shinde, Reshma, et al.
Publicado: (2016)

Real-world use of osimertinib for epidermal growth factor receptor T790M-positive non-small cell lung cancer in Japan
por: Ohe, Yuichiro, et al.
Publicado: (2020)

Regulatory Approval With Real-World Data From Regulatory Science Perspective in Japan
por: Maeda, Hideki, et al.
Publicado: (2022)

Epidemiologic Research on Malformations Associated with Cleft Lip and Cleft Palate in Japan
por: Koga, Hiroshi, et al.
Publicado: (2016)

Real-world evidence of treatment for relapse of noninfectious uveitis in tertiary centers in Japan: A multicenter study
por: Takeuchi, Masaru, et al.
Publicado: (2019)

Continuing EGFR-TKI beyond radiological progression in patients with advanced or recurrent, EGFR mutation-positive non-small-cell lung cancer: an observational study
por: Goto, Yasushi, et al.
Publicado: (2017)

Median Age at HPV Infection Among Women in the United States: A Model-Based Analysis Informed by Real-world Data
por: Prabhu, Vimalanand S, et al.
Publicado: (2021)

Real-world experience with monthly and quarterly dosing of fremanezumab for the treatment of patients with migraine in Japan
por: Suzuki, Shiho, et al.
Publicado: (2023)

Real‐world data of atezolizumab plus carboplatin and etoposide in elderly patients with extensive‐disease small‐cell lung cancer
por: Shiono, Ayako, et al.
Publicado: (2022)

Real-world evidence of safety and influence for lung cancer surgery under COVID-19 pandemic in Japan
por: Kato, Taketo, et al.
Publicado: (2023)

Current Status, Challenges, and Future Perspectives of Real-World Data and Real-World Evidence in Japan
por: Hiramatsu, Katsutoshi, et al.
Publicado: (2021)

Real-World Evidence of Diagnostic Testing for Driver Oncogene Mutations in Lung Cancer in Japan
por: Yatabe, Yasushi, et al.
Publicado: (2020)

Real-World Patient Characteristics and Treatment Patterns of Naldemedine for the Treatment of Opioid-Induced Constipation in Patients with Cancer: A Multicenter Retrospective Chart Review Study
por: Hiruta, Eriko, et al.
Publicado: (2021)

Clinical features of lenvatinib for unresectable hepatocellular carcinoma in real‐world conditions: Multicenter analysis
por: Hiraoka, Atsushi, et al.
Publicado: (2018)

Characteristics of COVID-19 in multicenter ICUs in Japan
por: Ohbe, Hiroyuki, et al.
Publicado: (2021)

Cumulative cancer incidence and mortality after kidney transplantation in Japan: A long‐term multicenter cohort study
por: Imamura, Ryoichi, et al.
Publicado: (2020)

Prognostic factor of lenvatinib for unresectable hepatocellular carcinoma in real‐world conditions—Multicenter analysis
por: Hiraoka, Atsushi, et al.
Publicado: (2019)

Adherence to omalizumab: A multicenter "real-world" study
por: Campisi, Raffaele, et al.
Publicado: (2020)

Real-World Data on Clinical Features, Outcomes, and Prognostic Factors in Multiple Myeloma from Miyazaki Prefecture, Japan
por: Akizuki, Keiichi, et al.
Publicado: (2020)

A Retrospective, Multicenter, Observational Study to Evaluate Clinical Outcomes of Lorlatinib After Alectinib in Patients With ALK-Positive NSCLC in Japan
por: Goto, Yasushi, et al.
Publicado: (2023)

The effects of perioperative oral management on perioperative serum albumin levels in patients treated surgically under general anesthesia: A multicenter retrospective analysis in Japan
por: Yamada, Shin-ichi, et al.
Publicado: (2021)

Real‐world evidence on disseminated intravascular coagulation from Japan
por: Hisamune, Ryo, et al.
Publicado: (2023)

Real-world use of enzalutamide in men with nonmetastatic castration-resistant prostate cancer in Japan
por: Yokomizo, Akira, et al.
Publicado: (2021)

Real‑world treatment outcomes among patients with metastatic pancreatic cancer in Japan: The Tokushukai real‑world data project
por: Shimoyama, Rai, et al.
Publicado: (2023)

1577. Real-World, Multicenter Experience with Eravacycline for Various Infections
por: Alosaimy, Sara, et al.
Publicado: (2020)

A Real-world Multicenter Outpatient Experience of Ceftolozane/Tazobactam
por: Van Anglen, Lucinda J, et al.
Publicado: (2023)

Real-World Outcomes of Treating Advanced Breast Cancer Patients With Palbociclib: A Multicenter Retrospective Cohort Study in Japan—The KBCOG-14 Study
por: Odan, Nina, et al.
Publicado: (2020)

Correction to: Real-world use of enzalutamide in men with nonmetastatic castration-resistant prostate cancer in Japan
por: Yokomizo, Akira, et al.
Publicado: (2022)

Hyperkalemia in Real-World Patients Under Continuous Medical Care in Japan
por: Kashihara, Naoki, et al.
Publicado: (2019)

Real‐world etiologies and treatments of pediatric short bowel syndrome in Japan
por: Tazuke, Yuko, et al.
Publicado: (2022)

Assessment of real-world application of advanced prostate cancer management in Japan
por: Aragon-Ching, Jeanny B.
Publicado: (2022)

Real‐world results with IgPro20 for hypo‐ or agammaglobulinemia in Japan
por: Imai, Kohsuke, et al.
Publicado: (2022)

Strategies to Address Current Challenges in Real-World Evidence Generation in Japan
por: Laurent, Thomas, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_8srgebr86cbd3avdcc94j6i4aj